These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Use of Persantine in preventing thromboembolism following valve replacement. Arrants JE, Hairston P. Am Surg; 1972 Aug; 38(8):432-5. PubMed ID: 5045046 [No Abstract] [Full Text] [Related]
4. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease. Ribeiro PA, Al Zaibag M, Idris M, Al Kasab S, Davies G, Mashat E, Wareham E, Al Fagih M. J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564 [Abstract] [Full Text] [Related]
5. [Prevention of systemic thromboembolic accidents in patients with artificial valve prostheses. Prospective study of an antivitamins K-dipyridamole combination]. Starkman C, Estampes B, Vernant P, Acar J. Arch Mal Coeur Vaiss; 1982 Jan; 75(1):85-8. PubMed ID: 6803719 [No Abstract] [Full Text] [Related]
18. [Long-term results after isolated aortic and mitral valve replacement with a prosthesis (author's transl)]. Domanig E, Helmer F, Navrátil J, Wolner E. Wien Klin Wochenschr; 1977 Jun 10; 89(12):409-12. PubMed ID: 878484 [Abstract] [Full Text] [Related]
19. Five-years actuarial analysis after heart valve replacement with the St. Jude medical prosthesis. Fraedrich G, Höge R, Fiedler R, Hehrlein FW. Z Kardiol; 1986 Jun 10; 75 Suppl 2():282-5. PubMed ID: 3727702 [No Abstract] [Full Text] [Related]
20. Long-term performance of the St. Jude Medical valve: low incidence of thromboembolism and hemorrhagic complications with modest doses of warfarin. Kopf GS, Hammond GL, Geha AS, Elefteriades J, Hashim SW. Circulation; 1987 Sep 10; 76(3 Pt 2):III132-6. PubMed ID: 3621536 [Abstract] [Full Text] [Related] Page: [Next] [New Search]